Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Insulet to Host an Investor Webcast to Discuss Omnipod® 5 Pivotal Data
Omnipod 5 is the world’s first tubeless, wearable automated insulin delivery system that continuously adapts insulin delivery based on glucose levels and trends ACTON, Mass. --(BUSINESS WIRE)--Mar. 16, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in
View HTML
Toggle Summary Insulet Reports Full Year 2020 Revenue Increase of 23% and Fourth Quarter 2020 Revenue Increase of 18% Year-Over-Year
Represents 5th Consecutive Year of Over 20% Revenue Growth; Record Quarterly Revenue ACTON, Mass. --(BUSINESS WIRE)--Feb. 23, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System
View HTML
Toggle Summary Insulet to Present at Upcoming Investor Conferences
ACTON, Mass. --(BUSINESS WIRE)--Feb. 8, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming virtual investor conferences: The Citi
View HTML
Toggle Summary Insulet’s Omnipod DASH® System Now Available in Canada
ACTON, Mass. --(BUSINESS WIRE)--Jan. 18, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the launch of the Omnipod DASH ® Insulin Management
View HTML
Toggle Summary Insulet to Announce Fourth Quarter and Full Year 2020 Financial Results on February 23, 2021
ACTON, Mass. --(BUSINESS WIRE)--Jan. 11, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full year of 2020 on
View HTML
Toggle Summary Insulet to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference
ACTON, Mass. --(BUSINESS WIRE)--Dec. 21, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 39 th Annual J.P.
View HTML
Toggle Summary Insulet to Present at Upcoming Investor Conferences
ACTON, Mass. --(BUSINESS WIRE)--Nov. 9, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming virtual investor conferences: The
View HTML
Toggle Summary Insulet Reports Third Quarter 2020 Revenue Increase of 22% Year-Over-Year
Includes Total Omnipod ® Revenue Growth of 20% ACTON, Mass. --(BUSINESS WIRE)--Nov. 4, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial
View HTML
Toggle Summary Insulet Raises Awareness for Diabetes Throughout November
ACTON, Mass. --(BUSINESS WIRE)--Nov. 2, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced special activities to support its ongoing commitment to
View HTML
Toggle Summary Insulet Recognized as Global Impact Corporate Hero and Manufacturer of the Year
ACTON, Mass. --(BUSINESS WIRE)--Oct. 29, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced it is being honored by two Massachusetts agencies for the
View HTML
Toggle Summary Insulet Appoints Wayne A. I. Frederick, M.D., to Board of Directors
ACTON, Mass. --(BUSINESS WIRE)--Oct. 20, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that Wayne A. I.
View HTML
Toggle Summary Insulet to Announce Third Quarter 2020 Financial Results on November 4, 2020
ACTON, Mass. --(BUSINESS WIRE)--Oct. 5, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the third quarter of 2020 on
View HTML
Toggle Summary Insulet Expands its Offering of Omnipod DASH® Insulin Management System
ACTON, Mass. --(BUSINESS WIRE)--Sep. 21, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it is commercially launching its Omnipod DASH ® Insulin
View HTML
Toggle Summary Insulet to Present at Upcoming Investor Conferences
ACTON, Mass. --(BUSINESS WIRE)--Aug. 24, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two virtual investor conferences: The Baird 2020 Global
View HTML
Toggle Summary Insulet Reports Second Quarter 2020 Revenue Increase of 28% Year-Over-Year
Includes Total Omnipod ® Revenue Growth of 26% ACTON, Mass. --(BUSINESS WIRE)--Aug. 6, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial
View HTML